Copyright
©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 598-609
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.598
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.598
CDT group (n = 21) | AngioJet group (n = 44) | χ2/t | P values | |
Age (yr old) | 55.24 ± 11.92 | 56.84 ± 14.19 | -0.447 | 0.656 |
Male | 13 (61.90) | 21 (47.73) | 1.145 | 0.285 |
Affected limbs (left) | 10 (47.62) | 20 (45.54) | 0.027 | 0.87 |
Duration of symptoms | 11.23 ± 2.17 | 11.59 ± 2.08 | -0.63 | 0.531 |
Risk factors (fracture types) | ||||
Below the knee | 6 (28.57) | 8 (18.18) | 0.913 | 0.657 |
Knee | 6 (28.57) | 14 (31.82) | ||
Above the knee | 9 (42.86) | 22 (50.0) | ||
Scope of thrombosis | ||||
Femoral/popliteal/calf | 5 (23.81) | 6 (13.64) | 0.448 | 0.503 |
Popliteal/calf | 16 (76.19) | 38 (86.36) | ||
Filter types | ||||
Denali | 22 (100.0) | 41 (93.18) | – | 0.545 |
- Citation: Li JY, Liu JL, Tian X, Jia W, Jiang P, Cheng ZY, Zhang YX, Liu X, Zhou M. Clinical outcomes of AngioJet pharmacomechanical thrombectomy versus catheter-directed thrombolysis for the treatment of filter-related caval thrombosis. World J Clin Cases 2023; 11(3): 598-609
- URL: https://www.wjgnet.com/2307-8960/full/v11/i3/598.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i3.598